Peptide Hubs
LIVAGEN 20 MG
CLASSIFICATION: CYTOKINE PEPTIDE
ACTIVE SUBSTANCE: LIVAGEN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 20 MG)
ACTIVE HALF-LIFE: 2–6 HOURS
DOSAGE: 10–20 MG/WEEK (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
Out of stock
Livagen 20 mg – Peptide Hubs
Livagen is a short peptide derived from thymic and liver tissue, classified as a gene expression regulatory peptide. It has been extensively studied in the context of DNA repair, chromatin remodeling, and cellular senescence. Peptide Hubs delivers a research-grade 20 mg vial of lyophilized Livagen designed for advanced anti-aging, epigenetic, and immunomodulatory studies.
Mechanism of Action
Livagen exerts its biological effects by influencing histone acetylation and DNA methylation, thereby modulating gene expression related to cellular longevity, inflammation, and tissue regeneration. It is known to interact with heterochromatin structures, supporting genomic stability and suppressing age-associated transcriptional errors. This PubMed study on Livagen explores its function in DNA repair and immunoregulation.
Primary Research Applications
- DNA repair and epigenetic regulation studies
- Senescence and longevity-focused models
- Immune modulation and thymic support protocols
- Tissue regeneration and chromatin remodeling experiments
Livagen is often stacked with FOX04-DRI for senescence-clearing synergy or Humanin for mitochondrial repair and neuroprotection. It may also be integrated into antioxidant or DNA repair-focused stacks using L-Glutathione or GHK Basic.
Suggested Experimental Use
- Dosage: 10–20 mg per week, split into 2–3 sessions
- Administration: Subcutaneous or intramuscular injection
- Cycle Duration: 4–12 weeks depending on research focus
Stacking Recommendations
- DSIP – to support sleep and circadian-linked gene expression recovery
- B7-33 – for fibrosis control and tissue rejuvenation
- Chonluten – to support immune modulation and epithelial repair
- Semaglutide – for metabolic stability under genomic stress
Safety & Legal Status
Livagen is a synthetic research peptide not approved for human or veterinary use. It is used in laboratory environments for epigenetic and regenerative exploration. It poses no hepatotoxicity, hormonal suppression, or aromatization risk. For insights on related studies, refer to ongoing data at ClinicalTrials.gov.
Frequently Asked Questions
What is Livagen used for in research?
Livagen is used in epigenetic, DNA repair, and anti-aging research. It regulates gene expression and supports chromatin structure maintenance.
Does Livagen affect hormone levels?
No. Livagen is not a hormonal peptide. It acts through gene modulation and does not influence estrogenic or androgenic activity.
Can Livagen be stacked with FOX04-DRI?
Yes. Researchers commonly stack Livagen with FOX04-DRI to explore cellular senescence clearance and genomic stabilization synergy.
Is Livagen approved for human use?
No. Livagen is not FDA-approved and is strictly intended for laboratory research involving genomic and anti-aging mechanisms.
No reviews found
Please log in to write LIVAGEN 20 MG review.